Mice were monitored daily following the injection to ensure recovery. Kitten Milk Replacement (Santa Cruz #sc-362120) was fed to mice daily for up to 2 wk following the injection to aid recovery and meloxicam was injected subcutaneously to alleviate pain if necessary. Motor function was assessed using the cylinder test each week following the injection (see below). 4 wk following 6-OHDA injection, mice were quickly anesthetized using isoflurane and decapitated, and their brains were fresh-frozen as described above for FISH.
H116 5mg
The H116-5MG is a laboratory product manufactured by Merck Group. It is a chemical compound used for research and development purposes. No further details about its core function or intended use can be provided in an unbiased and factual manner.
4 protocols using h116 5mg
Modeling Parkinson's Disease in Mice
Mice were monitored daily following the injection to ensure recovery. Kitten Milk Replacement (Santa Cruz #sc-362120) was fed to mice daily for up to 2 wk following the injection to aid recovery and meloxicam was injected subcutaneously to alleviate pain if necessary. Motor function was assessed using the cylinder test each week following the injection (see below). 4 wk following 6-OHDA injection, mice were quickly anesthetized using isoflurane and decapitated, and their brains were fresh-frozen as described above for FISH.
6-OHDA and NAC Neuroprotection Protocol
Parkinson's Disease Rat Model Protocol
Preventing Long-Term Memory Consolidation
Ablation of dopamine neurons projecting to TS bilaterally was done as previously described (Menegas et al., 2018) (link). Briefly, a solution of 28.5 mg desipramine (Sigma-Aldrich, D3900-1G), 6.2 mg pargyline (Sigma-Aldrich, P8013-500MG), 10 mL water, and NaOH to pH 7.4 was prepared and injected i.p. to animals at 10 mg/kg. This solution prevents dopamine uptake in noradrenaline neurons, and increases the selectivity of uptake by dopamine neurons. Next, a solution of 10 mg/mL 6-hydroxydopamine (6-OHDA; Sigma-Aldrich, H116-5MG) in 0.2% ascorbic acid (Sigma-Aldrich, PHR1008-2G) in saline (0.9% NaCl; Sigma-Aldrich, PHR1008-2G) was injected bilaterally during stereotactic surgeries as described above into TS. The saline solution included a small amount of ascorbic acid to prevent 6-OHDA from breaking down. To further protect 6-OHDA from breaking down, this solution was kept on ice, wrapped in aluminum foil, and used within 3 h of mixing. If the solution turned brown, it was discarded, as this indicates that the 6-OHDA had broken down.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!